What is Cardiome's Business?
Cardiome Pharma Corp. is a research-based biopharmaceutical company dedicated to the discovery and development of new therapies that will improve the health of patients around the world. Cardiome has particular research expertise in ion-channels and diseases associated with ion-channel dysfunction, which can range from cardiovascular to cancer to neurological and CNS disorders.
What exchange is Cardiome traded on, and what is the symbol?
Cardiome is traded on the Nasdaq Global Market under the symbol "CRME" and the Toronto Stock Exchange under the symbol "COM".
When are Cardiome's fiscal quarter and year-end dates, and what are the corresponding dates for release of results?
As of 2003, Cardiome operates on a fiscal year ending December 31; previously the year end was November 30. Our quarterly reporting periods are March 31, June 30, September 30 and December 31. Annual reports are reported within 90 days of the end of the year and quarterly results are reported within 45 days of the end of each quarter.
Who is Cardiome's Transfer Agent?
Communication concerning transfer requirements, lost certificates, change of address and other similar inquiries should be addressed to our transfer agent:
Computershare Trust Company of Canada
510 Burrard Street, 2nd Floor
Vancouver, B.C. V6C 3B9
Telephone: 604-661-9400
Fax: 604-661-9549
How can I access Cardiome's regulatory filings?
Our Canadian filings are available on SEDAR at www.sedar.com and our U.S. filings are available on EDGAR at www.sec.gov/edgar.shtml.
When is Cardiome's Annual General Meeting?
Our Annual General Meeting was held on June 6th at 1:30pm in the 2nd Floor Boardroom at 6190 Agronomy Road, Vancouver, British Columbia. Our 2012 AGM is not yet scheduled.
What is Cardiome's Code of Conduct?
Cardiome's Code of Conduct can be accessed here
Who are the independent auditors for Cardiome?
KPMG LLP
How can I receive email updates when new press releases are issued?
To be added to Cardiome's email list, click here